Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $38.0000 (0%) ($0.0000 - $0.0000) on Wed. Nov. 26, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.41% (three month average) | RSI | 32 | Latest Price | $38.0000(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -2.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) JNK(7%) VT(7%) XLF(7%) EWG(6%) EWI(6%) | Factors Impacting CAPR price | CAPR will decline at least -2.205% in a week (0% probabilities). VIXM(-5%) TLT(-4%) SHY(-2%) IBB(-2%) GLD(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.205% (StdDev 4.41%) | Hourly BBV | 0 () | Intraday Trend | INF% | | | |
|
Resistance Level | $39.61 | 5 Day Moving Average | $38.34(-0.89%) | 10 Day Moving Average | $39.39(-3.53%) | 20 Day Moving Average | $39.61(-4.06%) | To recent high | -13.2% | To recent low | 8.6% | Market Cap | $749m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |